Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Standard BioTools Inc LAB

Technology Scientific & Technical Instruments
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.


NDAQ:LAB - Post by User

Standard BioTools Inc > fldm receives Add'l $22 M contract for covid testing expans.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(77)
•••
Post by Humaniston Sep 29, 2020 10:39am
85 Views
Post# 31634712

fldm receives Add'l $22 M contract for covid testing expans.

fldm receives Add'l $22 M contract for covid testing expans.Fluidigm receives additional $22M funding for expansion of Covid testing capacity


Sep. 29, 2020 10:07 AM ET|About: Fluidigm Corporation (FLDM)|By: Manshi Mamtora, CFA, SA News Editor 

On September 28, Fluidigm (FLDM +3.0%) signs a definite agreement with National Institute of Health for a program aimed at increasing the number, type, and availability of tests for Covid-19.

The project funding increased ~$22M, to bring the total contract value at $34M.

This will help expand production capacity and throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology.

The project will be funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, NIH, Department of Health and Human Services.

p.s. i seem to bethe only one posting here although many people read my post, c'mon guys i aminterested in whatyou have to say/contribute

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities